Publication date:
15 April 2016
This regulatory impact statement provides an analysis of the proposed regulatory change to allow nurse practitioners and optometrists, with Therapeutic Product Authorisation, to issue standing orders.
The change is expected to improve timeliness and ease of access to medicines for particular people and enable more efficient service delivery in health care teams.
